The CDMO Surge: Outsourcing in the Antibodies Market
A significant structural shift is occurring in the biopharmaceutical industry as companies move away from in-house production toward specialized partnerships. A comprehensive Antibodies Market Analysis shows that the Antibodies Contract Manufacturing (CDMO) Market is set to grow from $19.7 billion in 2025 to $51.8 billion by 2035. This transition is driven by the increasing complexity of...
0 Comments 0 Shares 101 Views 0 Reviews